PHVS
Pharvaris N.V.
NASDAQ · NLHealthcareBiotechnology
$33.55-3.98%
Price as of Jul 20, 2026
PHVS growth
Pharvaris N.V. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- —
- EBITDA
- -11.2%
- EBIT
- —
- EPS
- -0.7%
- Free cash flow
- -9.8%
- Operating cash flow
- -10.3%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +0.6%
Three-year CAGR
- Revenue
- —
- EBITDA
- -19.0%
- EBIT
- -16.6%
- Net income
- -30.9%
- EPS
- -19.8%
- Free cash flow
- -13.7%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.